Reines, Scott A

A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 402

Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Keller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 286

Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial

Berry-Kravis, E. M., Harnett, M. D., Reines, S. A., Reese, M. A., Ethridge, L. E., Outterson, A. H., Michalak, C., Furman, J., & Gurney, M. E. (2021) · Nature Medicine

Genetics and Neurodevelopmental DisordersPhosphodiesterase function and regulation

Cited by 131

Misuse of Tramadol in the United States: An Analysis of the National Survey of Drug Use and Health 2002-2017

Reines, S. A., Goldmann, B., Harnett, M., & Lu, L. (2020) · Substance Abuse: Research and Treatment

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 41